Skip to main content

Table 1 Clinical characteristics of a cohort of 33 brain specimens from people with HIV

From: Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder

 Cognitive normal (n = 10)Asymptomatic neurocognitive impairment (n = 10)Minor neurocognitive dysfunction (n = 10)HIV-associated dementia (n = 3)
Age41.7 ± 8.141.7 ± 10.843.1 ± 6.740.7 ± 2.1
Sex (fm:m)0:101:091:091:02
Postmortem interval33.3 ± 67.521.4 ± 28.415.5 ± 14.49.3 ± 3.01
Education13.0 ± 2.312.22 ± 3.412.0 ± 3.4616.0 ± 3.5
CD4151.6 ± 151.268.7 ± 73.935.3 ± 55.498.0 ± 155.1
VL (log)3.3 ± 1.63.9 ± 1.35.0 ± 0.84.4 ± 2.4
Duration on ART (months)53.3 ± 28.256.3 ± 86.535.7 ± 19.616.0 ± 0.0